News
Cantor Fitzgerald analyst Carter Gould downgraded Amgen (AMGN) to Neutral from Overweight with a price target of $305, down from $340, as the ...
Cantor Fitzgerald downgraded Amgen (AMGN) to Neutral from Overweight.Stay Ahead of the Market: Discover outperforming stocks and invest ...
Bolsa hoy e Ibex 35, en directo: últimas noticias de los mercados, Euríbor, Wall Street, Nasdaq, Dow Jones, criptomonedas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback